Evidence map›Paper›PMID 33885235›Full record

Trial reportRadiology and oncology2020

Effect of the oral intake of astaxanthin on semen parameters in patients with oligo-astheno-teratozoospermia: a randomized double-blind placebo-controlled trial.

Senka Imamovic Kumalic, Irma Virant Klun, Eda Vrtacnik Bokal, Bojana Pinter

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Radiology and oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 5 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 5 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Antioxidants for male subfertility.The Cochrane database of systematic reviews · 2022
    Pooled it
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. The effect of astaxanthin on human sperm parameters after cryopreservation.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Senka Imamovic KumalicDivision of Obstetrics and Gynecology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Irma Virant KlunDivision of Obstetrics and Gynecology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Eda Vrtacnik BokalDivision of Obstetrics and Gynecology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Bojana PinterDivision of Obstetrics and Gynecology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
University of Ljubljana · SILjubljana University Medical Centre · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigher concentrations of seminal reactive oxygen species may be related to male infertility. Astaxanthin with high antioxidant activity can have an impact on the prevention and treatment of various health conditions, including cancer. However, efficacy studies on astaxanthin in patients with oligospermia with/without astheno- or teratozoospermia (O±A±T) have not yet been reported. Our aim was to evaluate the effect of the oral intake of astaxanthin on semen parameters. PATIENTS AND

methodsIn a randomized double-blind trial, 80 men with O±A±T were allocated to intervention with 16 mg astaxanthin orally daily or placebo. At baseline and after three months basic semen parameters, sperm deoxyribonucleic acid (DNA) fragmentation and mitochondrial membrane potential (MMP) of spermatozoa and serum follicle-stimulating hormone (FSH) value were measured.

resultsAnalysis of the results of 72 patients completing the study (37 in the study group, 35 in the placebo group) did not show any statistically significant change, in the astaxanthin group no improvements in the total number of spermatozoa, concentration of spermatozoa, total motility of spermatozoa, morphology of spermatozoa, DNA fragmentation and mitochondrial membrane potential of spermatozoa or serum FSH were determined. In the placebo group, statistically significant changes in the total number and concentration of spermatozoa were determined.

conclusionsThe oral intake of astaxanthin did not affect any semen parameters in patients with O±A±T.

Indexed as

Administration, OralAdultAsthenozoospermiaDouble-Blind MethodHumansMaleProspective StudiesReactive Oxygen SpeciesSemenXanthophyllsastaxanthineReactive Oxygen SpeciesXanthophyllsantioxidantcancerDNA fragmentationmale infertilityoligo-astheno-teratozoospermiasemen quality

Identifiers

PMID33885235
PMCPMC7877271
OpenAlexW3094551512

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.